Risk of interstitial lung disease with the use of programmed cell death 1 (PD-1) inhibitor compared with programmed cell death ligand 1 (PD-L1) inhibitor in patients with breast cancer: A systematic review and meta-analysis
- Resource Type
- Review Article
- Source
- In
Cancer Pathogenesis and Therapy April 2024 2(2):91-102 - Subject
- Language
- ISSN
- 2949-7132